Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by Pandoraon Aug 21, 2024 3:21pm
66 Views
Post# 36190520

RE:RE:RE:New Press Release - Ventripoint Receives Medical Device License from Health Canada to Sell Next Generation, AI-powered, Heart-scanning Technology

RE:RE:RE:New Press Release - Ventripoint Receives Medical Device License from Health Canada to Sell Next Generation, AI-powered, Heart-scanning Technology
riverrrow wrote: How is this approved in Canada so quickly but still pending in the USA?


It looks like they were all submitted at the same time i.e. beginning of May:

"Ventripoint submitted VMS+4.0 for clearance by FDA on May 1, a requirement for significant
software and hardware updates and diagnostic advances. We are also pursuing regulatory
clearance in other key markets such as the E.U., U.K and Canada to make this newest version of
Ventripoint available to the global community. Ventripoint’s current scanning technology has
already received FDA, Health Canada and similar regulatory approvals in the United Kingdom and the European Union, and is being used by leading hospitals in the U.S., E.U., U.K. and
Canada.”


<< Previous
Bullboard Posts
Next >>